Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 27.2537.67-7.1420.1417.54

What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?

The latest Core EBITDA Growth ratio of MANKIND PHARMA is 27.25 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202527.25
Mar202437.67
Mar2023-7.14
Mar202220.14
Mar202117.54

How is Core EBITDA Growth of MANKIND PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 27.25
-27.66
Mar2024 37.67
Positive
Mar2023 -7.14
Negative
Mar2022 20.14
14.82
Mar2021 17.54 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,302.2 Cr 1.5% -3.5% -10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,872.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,706.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹127,449.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,125.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹104,827.0 Cr -0.5% -4.2% -6.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-3.5%

-10.6%

SENSEX

1.8%

1.9%

2.4%


You may also like the below Video Courses